🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Spain / NCT07694063
Recruiting Not applicable

Online Hatha Yoga Program as an Add-On Therapy for Episodic High-Frequency Migraine

NCT07694063 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-01-27
Last updated
2026-07-09

Condition(s) studied

Migraine

Investigational drug(s) / intervention(s)

Control group (receiving standard medical therapy alone)Hatha yoga

Control group (receiving standard medical therapy alone): * Continuation of usual pharmacological migraine treatment * No structured exercise/yoga program * Usual clinical follow-up * Post-study access to yoga program offered

Hatha yoga: * Online Hatha Yoga Program (12 weeks + 2-week follow-up) * 2 sessions per week * 30-45 minutes per session * Asynchronous video-based home practice * Standard pharmacological treatment maintained

Study summary

This randomized controlled trial aims to evaluate the effectiveness and feasibility of an online Hatha yoga program as an adjunct (add-on) therapy for patients with high-frequency episodic migraine. Participants will be randomly assigned to either an intervention group receiving a 12-week home-based online Hatha yoga program in addition to usual pharmacological treatment, or a control group receiving usual pharmacological care only. Outcomes include migraine frequency, pain intensity, functional disability, sleep quality, psychological symptoms, and adherence.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria * Adults aged 18-65 years * Diagnosis of episodic high-frequency migraine according to ICHD criteria * Diagnosis confirmed by a neurologist * At least 1-year history of migraine * Receiving stable pharmacological treatment for ≥3 months before enrollment * Willing to maintain stable medication during the study * Ability to understand study procedures and complete assessments * Signed informed consent * Willingness to be randomized Exclusion Criteria * Other significant neurological disorders * Severe psychiatric conditions affecting participation * Medical contraindications to moderate physical activity * Chronic migraine (≥15 headache days/month) * Use of more than one preventive migraine medication * Lack of Spanish language comprehension * Lack of internet access or digital skills for online intervention

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Virgen del Rocio Seville Sevilla Recruiting

More University of Seville trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07694063 on ClinicalTrials.gov ↗ ← All trials in Spain